Ftse Mib
34.659,55
0,00%
DAX
18.677,87
-0,45%
S&P 500
5.306,04
0,02%
NASDAQ
0,00
0,00%
Bitcoin
68.610,54
0,47%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Penwest Pharmaceuticals CO. (MM) (PPCO) Penwest Pharmaceuticals CO. (MM) (PPCO) Notizie

PPCO

Penwest (PPCO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PPCO
DataOraFonteTitoloSimboloCompagnia
04/11/201021:23PR Newswire (US)Penwest Pharmaceuticals Shareholders Approve Merger With Subsidiary of Endo PharmaceuticalsNASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
02/11/201011:00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
01/11/201012:30PR Newswire (US)Endo Pharmaceuticals Reports Strong Third Quarter 2010 Financial Results; Reaffirms 2010 Financial Guidance and Provides FinanciNASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
29/10/201023:16Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
29/10/201023:11Edgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
25/10/201022:35Edgar (US Regulatory)-National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
15/10/201022:45PR Newswire (US)Penwest Pharmaceuticals Announces Intention to Terminate NASDAQ Listing and RegistrationNASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
14/10/201017:15Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
07/10/201023:07Edgar (US Regulatory)Current report filing (8-K)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
07/10/201015:35Dow Jones NewsWatson Pharma Gets License To Sell Generic Opana In 2012NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
01/10/201022:57Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
30/09/201023:00PR Newswire (US)Penwest Pharmaceuticals Sets Special Shareholders Meeting Date for Approval of Merger With Subsidiary of Endo PharmaceuticalsNASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
27/09/201023:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
27/09/201023:13Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
24/09/201012:04Edgar (US Regulatory)Proxy Soliciting Materials (revised) (PRER14A)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
22/09/201016:08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
20/09/201023:28Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
20/09/201023:21Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
20/09/201022:15PR Newswire (US)Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Penwest PharmaceuticalsNASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
07/09/201023:31Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
07/09/201012:06Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (PREM14A)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
20/08/201018:51Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
20/08/201018:45Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
14/08/201000:09Business WireFinkelstein Thompson LLP Announces Investigation of Penwest Pharmaceuticals, Co.NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
13/08/201012:06Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
12/08/201018:47Business WireLaw Office of Abe Shainberg Announces Investigation of Possible Breach of Fiduciary Duty by the Board of Penwest Pharmaceutic...NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
12/08/201016:26Business WireFaruqi & Faruqi, LLP Announces Investigation Related to the Acquisition of Penwest Pharmaceuticals Co. - PPCONASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
11/08/201022:22Business WireThe Law Office of Vincent Wong Announces Investigation of Possible Breach of Fiduciary Duty by the Board of Penwest Pharmaceu...NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
11/08/201002:56Business WireLaw Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Penwest Pharmaceuticals Co.NASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
10/08/201019:22Business WireRigrodsky & Long, P.A. Investigates Penwest Pharmaceuticals Co. BuyoutNASDAQ:PPCOPenwest Pharmaceuticals CO. (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PPCO

La tua Cronologia

KOSPI
610034
Representative Agricultu...
EU
INRA
Ishares II
BIT
F15787
Vontobel Financial Produ...
COIN
SUBX2USD
COIN
NAOSUST
NAOSToken
BIT
P10QP6
Bnp Paribas Issuance
USOTC
HCMC
Healthier Choices Manage... (PK)
NASDAQ
BSET
Bassett Furniture Indust...
POLO
JFIUSDT
JackPool.finance
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network